Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients
- PMID: 22295164
- PMCID: PMC3256551
- DOI: 10.3978/j.issn.2072-1439.2011.12.02
Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients
Abstract
Background: Patients successfully treated for Hodgkin's lymphoma (HL) are at known risk for subsequent malignancies, the most common of which is lung cancer. To date, no population-based study has analyzed prognostic variables for overall survival (OS) among HL survivors who developed non-small cell lung cancer (NSCLC).
Methods: For 187 HL patients who developed NSCLC (among 22,648 HL survivors), we examined the impact of the following variables on OS after NSCLC diagnosis: gender, race, sociodemographic status (based upon county of residence), calendar year and age at NSCLC diagnosis, NSCLC histology and grade, HL stage and subtype, radiation for HL and latency between HL and NSCLC. Patients were grouped by NSCLC stage as follows: localized, regional or distant. All patients were reported to the population-based Surveillance, Epidemiology, and End Results program. For those variables significant on univariate analyses, hazard ratios (HR) were derived from Cox proportional hazards model.
Results: Sociodemogaphic status, gender and latency between NSCLC and HL did not significantly affect OS of any NSCLC stage group. For patients with localized NSCLC, a history of mixed celluarlity HL was associated with a 3-fold improved OS (P=0.006). For patients with regional NSCLC, prior radiotherapy for HL was associated with a 2-fold worse OS (P=0.025).
Conclusions: A history of mixed cellularity HL subtype and a history of no radiotherapy for HL are favorable prognostic factors among patients who develop NSCLC. Further research into clinicopathologic and treatment-associated variables potentially affecting OS after second primary NSCLC among HL survivors is warranted.
Keywords: Hodgkin's lymphoma; Non-small cell lung cancer; cancer survivorship; population-based.
Conflict of interest statement
No potential conflict of interest.
Similar articles
-
Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.Cancer. 2011 Dec 15;117(24):5538-47. doi: 10.1002/cncr.26257. Epub 2011 Jun 20. Cancer. 2011. PMID: 21692074
-
The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database.PLoS One. 2023 May 17;18(5):e0285766. doi: 10.1371/journal.pone.0285766. eCollection 2023. PLoS One. 2023. PMID: 37195975 Free PMC article.
-
Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.J Clin Oncol. 2010 Dec 1;28(34):5088-96. doi: 10.1200/JCO.2010.29.5683. Epub 2010 Oct 25. J Clin Oncol. 2010. PMID: 20975072 Free PMC article.
-
Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.Lung. 2013 Feb;191(1):117-34. doi: 10.1007/s00408-012-9418-4. Epub 2012 Oct 6. Lung. 2013. PMID: 23053567 Review.
-
Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.J Clin Oncol. 2005 Oct 20;23(30):7604-13. doi: 10.1200/JCO.2005.02.6310. Epub 2005 Sep 26. J Clin Oncol. 2005. PMID: 16186595 Review.
Cited by
-
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.Clin Transl Oncol. 2016 Jan;18(1):99-106. doi: 10.1007/s12094-015-1342-7. Epub 2015 Nov 3. Clin Transl Oncol. 2016. PMID: 26530956
-
Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.Curr Hematol Malig Rep. 2012 Sep;7(3):200-7. doi: 10.1007/s11899-012-0128-z. Curr Hematol Malig Rep. 2012. PMID: 22743837 Review.
-
Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study).Transl Lung Cancer Res. 2020 Feb;9(1):90-102. doi: 10.21037/tlcr.2019.12.28. Transl Lung Cancer Res. 2020. PMID: 32206557 Free PMC article.
-
Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications.Insights Imaging. 2015 Jun;6(3):381-92. doi: 10.1007/s13244-015-0407-z. Epub 2015 Apr 28. Insights Imaging. 2015. PMID: 25917934 Free PMC article.
-
Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study.World J Surg Oncol. 2020 May 6;18(1):88. doi: 10.1186/s12957-020-01868-x. World J Surg Oncol. 2020. PMID: 32375797 Free PMC article.
References
-
- Donaldson SS, Hancock SL, Hoppe RT. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects. Cancer J Sci Am. 1999;5:325–33. - PubMed
-
- Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol. 2002;20:3484–94. - PubMed
-
- Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol. 2003;21:3431–9. - PubMed
-
- van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18:487–97. - PubMed
LinkOut - more resources
Full Text Sources